Reaction Details |
| Report a problem with these data |
Target | Cytochrome P450 11B1, mitochondrial |
---|
Ligand | BDBM50239795 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEBML_1667112 |
---|
IC50 | 3.0±n/a nM |
---|
Citation | Emmerich, J; van Koppen, CJ; Burkhart, JL; Hu, Q; Siebenbürger, L; Boerger, C; Scheuer, C; Laschke, MW; Menger, MD; Hartmann, RW Lead Optimization Generates CYP11B1 Inhibitors of Pyridylmethyl Isoxazole Type with Improved Pharmacological Profile for the Treatment of Cushing's Disease. J Med Chem60:5086-5098 (2017) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Cytochrome P450 11B1, mitochondrial |
---|
Name: | Cytochrome P450 11B1, mitochondrial |
Synonyms: | C11B1_HUMAN | CYP11B1 | CYPXIB1 | Cytochrome P450 11B, mitochondrial precursor | Cytochrome P450 11B1 | Cytochrome P450 11B1 (CYP11B1) | Cytochrome P450 11B1, mitochondrial | S11BH |
Type: | Enzyme |
Mol. Mass.: | 57591.44 |
Organism: | Homo sapiens (Human) |
Description: | P15538 |
Residue: | 503 |
Sequence: | MALRAKAEVCMAVPWLSLQRAQALGTRAARVPRTVLPFEAMPRRPGNRWLRLLQIWREQG
YEDLHLEVHQTFQELGPIFRYDLGGAGMVCVMLPEDVEKLQQVDSLHPHRMSLEPWVAYR
QHRGHKCGVFLLNGPEWRFNRLRLNPEVLSPNAVQRFLPMVDAVARDFSQALKKKVLQNA
RGSLTLDVQPSIFHYTIEASNLALFGERLGLVGHSPSSASLNFLHALEVMFKSTVQLMFM
PRSLSRWTSPKVWKEHFEAWDCIFQYGDNCIQKIYQELAFSRPQQYTSIVAELLLNAELS
PDAIKANSMELTAGSVDTTVFPLLMTLFELARNPNVQQALRQESLAAAASISEHPQKATT
ELPLLRAALKETLRLYPVGLFLERVASSDLVLQNYHIPAGTLVRVFLYSLGRNPALFPRP
ERYNPQRWLDIRGSGRNFYHVPFGFGMRQCLGRRLAEAEMLLLLHHVLKHLQVETLTQED
IKMVYSFILRPSMFPLLTFRAIN
|
|
|
BDBM50239795 |
---|
n/a |
---|
Name | BDBM50239795 |
Synonyms: | CHEMBL4067404 |
Type | Small organic molecule |
Emp. Form. | C18H15FN2 |
Mol. Mass. | 278.3235 |
SMILES | Cc1cncc(Cc2ccc(nc2)-c2ccccc2F)c1 |
Structure |
|